Inflammatory bowel disease, past, present and future: lessons from animal models

被引:131
|
作者
Mizoguchi, Atsushi [1 ,2 ]
Mizoguch, Emiko [2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Dept Pathol Expt Pathol, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Ctr Study Inflammat Bowel Dis, Sch Med, Boston, MA USA
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA
关键词
antigen sampling; autophagy; IBD; Breg; mucin; NOD2; Th17; TLRs;
D O I
10.1007/s00535-007-2111-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Accumulating data from animal models indicate that inflammatory bowel disease (IBD) is mediated by a much more complicated mechanism than previously predicted. For example, the role of an individual molecule in the pathogenesis of IBD distinctly differs depending on several factors, including the fundamental mechanism of induction of the disease, the target cell type, the phase of disease, and the environment. Therefore, it has been difficult in the past to fully explain the complicated mechanism. Novel concepts have recently been proposed to further explain the complicated mechanism of IBD. In this review, we introduce past, current, and possible future concepts for IBD models regarding T helper (Th) 1, Th2, and Th17, antigen sampling and presentation, regulatory cell networks, NOD2, Toll-like receptors, bacteria/epithelia interaction, stem cells, autophagy, microRNAs, and glycoimmunology, and we also discuss the relevance of these new concepts, developed at the bench (in animal models), to the bedside.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [31] Lessons for human inflammatory bowel disease from experimental models
    Bhan, AK
    Mizoguchi, E
    Smith, N
    Mizoguchi, A
    CURRENT OPINION IN GASTROENTEROLOGY, 1999, 15 (04) : 285 - 290
  • [32] Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease
    Panes, Julian
    Salas, Azucena
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S633 - S640
  • [33] Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives
    Majumder, Snehali
    Shivaji, Uday Nagesh
    Kasturi, Rangarajan
    Sigamani, Alben
    Ghosh, Subrata
    Iacucci, Marietta
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (03) : 547 - 567
  • [34] The microbiota and inflammatory bowel disease: Insights from animal models
    Peloquin, Joanna M.
    Nguyen, Deanna D.
    ANAEROBE, 2013, 24 : 102 - 106
  • [35] 25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future
    D'Haens, Geert R.
    van Deventer, Sander
    GUT, 2021, 70 (07) : 1396 - 1405
  • [36] Animal models of inflammatory bowel disease: a review
    Goyal, Nidhi
    Rana, Ajay
    Ahlawat, Abhilasha
    Bijjem, Krishna Reddy V.
    Kumar, Puneet
    INFLAMMOPHARMACOLOGY, 2014, 22 (04) : 219 - 233
  • [37] Animal models of inflammatory bowel disease:: An overview
    Hoffmann, JC
    Pawlowski, NN
    Kühl, AA
    Höhne, W
    Zeitz, M
    PATHOBIOLOGY, 2002, 70 (03) : 121 - 130
  • [38] Animal models of inflammatory bowel disease: a review
    Nidhi Goyal
    Ajay Rana
    Abhilasha Ahlawat
    Krishna Reddy V. Bijjem
    Puneet Kumar
    Inflammopharmacology, 2014, 22 : 219 - 233
  • [39] Editorial: Animal models of Alzheimer's disease and other dementias: past, present, and future
    Moreno-Gonzalez, Ines
    Garcia-Martin, Jesus
    Marongiu, Roberta
    FRONTIERS IN AGING NEUROSCIENCE, 2025, 16
  • [40] Author Correction: Head-to-head trials in inflammatory bowel disease: past, present and future
    Lieven Pouillon
    Simon Travis
    Peter Bossuyt
    Silvio Danese
    Laurent Peyrin-Biroulet
    Nature Reviews Gastroenterology & Hepatology, 2021, 18 : 143 - 143